An interventional study of Tele-Nursing Education and Follow-up in Neurogenic Bladder and Clean Intermittent Catheterization, sponsored by Saglik Bilimleri Universitesi. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-16.
Sponsored by Saglik Bilimleri Universitesi · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 14 studies in Urinary Bladder, Neurogenic with a site in Turkey — none open to participants now, none under way, none of them phase 3. Urinary Bladder, Neurogenic · Turkey.
Among the 14 studies in Urinary Bladder, Neurogenic with a site in Turkey, this one is the 3rd largest by enrollment of the 10 interventional ones that give a count, is one of 2 that started in 2026, is one of 7 with no phase, and was the 14th registered.
191 studies on the registry are indexed under Urinary Bladder, Neurogenic; 40 are open to participants now.
Browse Urinary Bladder, Neurogenic studies →None of the 14 studies in Urinary Bladder, Neurogenic with a site in Turkey is open now. The open studies under Urinary Bladder, Neurogenic, anywhere →
Of the 25 Urinary Bladder, Neurogenic studies recruiting now, 11 (44%) set no upper age limit and 9 (36%) stop at 75 or younger; 7 take children under 18; 1 takes healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
14 studies; the count open now beside each. This study's row is marked.
First in 2007; this study’s year is marked. 2 started in 2026.
This study's enrollment of 84 is above the median of 40 across 126 interventional studies indexed under Urinary Bladder, Neurogenic.
Median enrollment 47 across the 10 interventional studies, 87 across the 4 observational. Of the 13 that completed or were terminated, 3 (23%) have results posted.
This tab as a report to print or save as PDF → With an account.
3 of 14 have an industry lead sponsor. The 10 most frequent:
Saglik Bilimleri Universitesi is the lead sponsor of 456 studies on the registry; 132 are open to participants now.
Saglik Bilimleri Universitesi has 1 study filed under Urinary Bladder, Neurogenic — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 14 studies in Urinary Bladder, Neurogenic with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to find out whether tele-nursing (education and follow-up provided by a nurse by telephone) after hospital discharge improves adherence, self-confidence and quality of life in patients who perform clean intermittent catheterization (CIC).
Clean intermittent catheterization is a method of emptying the bladder at regular intervals with a catheter in people who cannot empty their bladder on their own, such as people with spinal cord injury. After discharge, patients may have difficulty performing catheterization correctly and regularly, which can lead to complications and reduce their quality of life.
Adult patients performing CIC who were about to be discharged from a spinal cord injury rehabilitation clinic in Ankara, Türkiye, were included in the study. All patients received the clinic's routine discharge education. In addition, patients in the intervention group received 10 structured telephone sessions with a nurse during the 8 weeks after discharge. The control group received routine education only. Adherence to catheterization, self-confidence in performing catheterization and catheterization-related quality of life were measured before discharge and 8 weeks after discharge.
This quasi-experimental study with a pretest-posttest control group design was conducted between June and September 2026 at the Spinal Cord Injury Rehabilitation Clinic of Ankara Etlik City Hospital, Physical Medicine and Rehabilitation Hospital, Türkiye.
Sample size was calculated using G*Power 3.1.9.7 (effect size 0.19, alpha 0.05, power 0.90), which indicated a minimum of 38 participants per group. Allowing for a 10% dropout rate, a total of 84 patients (42 per group) were planned.
Eligible patients were assigned to the control or intervention group according to recruitment period; no randomization was performed. To prevent interaction and information sharing between groups, data from the control group were collected first, and recruitment of the intervention group began after the control group was completed.
Both groups received the clinic's routine discharge education. In the intervention group, a tele-nursing program was delivered for 8 weeks after discharge: telephone calls were made twice a week during the first two weeks and once a week thereafter, for a total of 10 calls lasting approximately 15-30 minutes each. The education covered 10 structured topics: basic information on catheterization, CIC procedure steps and hand hygiene, common problems and solutions, complications and their management, catheterization frequency and its importance, urine monitoring, adequate fluid intake, nutrition to prevent constipation, performing CIC in different settings and while traveling, and emergency management. All topics were covered with every patient, while the order and duration of the topics were tailored to individual needs. Calls were conducted in accordance with the Roter Interaction Analysis System (RIAS), based on patient-centered communication. Patients were also able to contact the researcher by phone or video call when needed.
Data were collected face-to-face before discharge (pretest) and by telephone 8 weeks after discharge (posttest), using the Patient Descriptive Characteristics Form, the Intermittent Catheterization Adherence Scale (ICAS), the Self-Confident Scale for Clean Intermittent Self-Catheterization (SCSCISC), the Intermittent Self-Catheterization Questionnaire (ISC-Q) and a Feedback Form. Data were analyzed using descriptive statistics, independent and paired t-tests and the chi-square test; effect size was assessed with Hedges' g, and p\<0.05 was considered statistically significant.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients received the clinic's routine discharge education and, in addition, a structured tele-nursing education and follow-up program for 8 weeks after discharge (10 telephone calls: twice a week in the first two weeks and once a week thereafter, each lasting approximately 15-30 minutes).
Behavioral: Tele-Nursing Education and Follow-up
Patients received only the clinic's routine discharge education. No additional intervention was provided by the researcher. Posttest data were collected by telephone 8 weeks after discharge.
A nurse-led tele-nursing program delivered by telephone for 8 weeks after discharge, consisting of 10 calls. The education covered 10 structured topics: basic information on catheterization, CIC procedure steps and hand hygiene, common problems and solutions, complications and their management, catheterization frequency, urine monitoring, adequate fluid intake, nutrition to prevent constipation, performing CIC in different settings and while traveling, and emergency management. The order and duration of topics were tailored to individual needs. Calls followed the Roter Interaction Analysis System (RIAS) for patient-centered communication.
Percentage of Participants Who Found the Tele-Nursing Program Useful
Assessed in the intervention group using a researcher-developed Feedback Form. This is not a scored scale; responses are reported as the number and percentage of participants who rated the telephone-based education and follow-up as useful.
Time frame: 8 weeks after discharge
Self-Confidence in Clean Intermittent Self-Catheterization
Assessed using the Self-Confident Scale for Clean Intermittent Self-Catheterization (SCSCISC). The scale consists of 16 items rated on a 5-point Likert scale. Higher scores indicate higher self-confidence.
Time frame: Baseline (before discharge) and 8 weeks after discharge
Catheterization-Related Quality of Life
Assessed using the Intermittent Self-Catheterization Questionnaire (ISC-Q). The questionnaire consists of 24 items in 4 domains (ease of use, convenience, discreetness and psychological well-being). Domain and total scores range from 0 to 100. Higher scores indicate better quality of life.
Time frame: Baseline (before discharge) and 8 weeks after discharge
Patient Satisfaction With the Tele-Nursing Program
Assessed in the intervention group using a researcher-developed 11-item Feedback Form including complications, healthcare visits and evaluations of the tele-nursing program.
Time frame: 8 weeks after discharge
Plan to share: No — Individual participant data will not be shared because participants did not provide consent for their data to be shared with other researchers, and sharing could compromise participant confidentiality. Aggregated results will be reported in publications.
No publications or documents are linked to this record.
Ran from Jun 2026 to primary completion in Sep 2026, 3 months.
Of 48 non-industry interventional studies with no phase under Urinary Bladder, Neurogenic, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 45. This study's 3 months is below that.
Counting every sponsor, half of 52 studies reached it within 32 months; a quarter within 8 and three quarters within 43.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Saglik Bilimleri Universitesi →